| Literature DB >> 34879842 |
Huibin Long1,2,3, Zhichang Li2,3, Dan Xing2,3, Yan Ke2,3, Jianhao Lin4,5.
Abstract
BACKGROUND: Numerous systematic reviews investigating the benefit of the usage of drainage after primary total hip or knee arthroplasty have been published with divergent conclusions. We aim to determine the best available evidence and consider risk of bias of these articles and to provide recommendations.Entities:
Keywords: Arthroplasty; Drainage; Evidence; Overview; Risk-of bias
Mesh:
Year: 2021 PMID: 34879842 PMCID: PMC8656000 DOI: 10.1186/s12891-021-04897-z
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Flowchart of the study selection process
General Description of the Characteristics of included Systematic Reviews
| Authors | Journal | Date of Last literature search | Date of Publication | No. of included studies | No. of gray literature |
|---|---|---|---|---|---|
| Parker et al. 2001 | Cochrane Database of Systematic reviews | May-01 | Oct-01 | 2/12/21 | 0 |
| Parker et al. 2004 | J Bone Joint Surg Am | Mar-03 | Jun-04 | 18 | 0 |
| Parker et al. 2007 | Cochrane Database of Systematic reviews | Mar-06 | Jul-07 | 2/19/36 | 0 |
| Zhang et al. 2011 | J Arthroplasty | May-10 | Dec-11 | 15 | 0 |
| Zhou et al. 2013 | Int Orthop | Dec-12 | Aug-13 | 2/20 | 0 |
| Chen et al. 2014 | Eur J Orthop Surg Traumatol | May-13 | Aug-13 | 16 | 0 |
| Kelly et al. 2014 | Surg Technol Int | NM | Mar-14 | 16 | 0 |
| Li et al. 2015 | J Orthop Surg Res | May-14 | Jan-15 | 3 | 0 |
| Quinn et al. 2015 | Int Orthop | Nov-12 | Jul-14 | 6 | 0 |
| Si et al. 2016 | BMC Musculoskelet Disord | Feb-16 | Apr-16 | 12 | 0 |
| Zan et al. 2016 | Int J Clin Exp Med | Jul-15 | Feb-16 | 12 | 0 |
| Zhang et al. 2018 | Medicine | Jun-17 | Jun-18 | 19 | 0 |
Databases Mentioned by Included Systematic Reviews during Literature Searches
| Authors | Search Database | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Medline | Embase | Cochrane | BIOSIS | EBSCO | CINAHL | CENTRAL | Others | ||
| Parker et al. 2001 | |||||||||
| Parker et al. 2004 | |||||||||
| Parker et al. 2007 | |||||||||
| Zhang et al. 2011 | |||||||||
| Zhou et al. 2013 | |||||||||
| Chen et al. 2014 | |||||||||
| Kelly et al. 2014 | |||||||||
| Li et al. 2015 | |||||||||
| Quinn et al. 2015 | |||||||||
| Si et al. 2016 | |||||||||
| Zan et al. 2016 | |||||||||
| Zhang et al. 2018 | |||||||||
Methodological Characteristics of Included Systematic Reviews
| Authors | Primary Study design | Level of evidence | Software | Sensitivity analysis | Subgroup analysis | GRADE evidence profiles |
|---|---|---|---|---|---|---|
| Parker et al. 2001 | Prospective trials | |||||
| Parker et al. 2004 | RCT and qRCT | |||||
| Parker et al. 2007 | Prospective trials | |||||
| Zhang et al. 2011 | RCT and qRCT | |||||
| Zhou et al. 2013 | RCT | |||||
| Chen et al. 2014 | RCT and qRCT | |||||
| Kelly et al. 2014 | RCT and qRCT | |||||
| Li et al. 2015 | RCT | |||||
| Quinn et al. 2015 | RCT | |||||
| Si et al. 2016 | RCT | |||||
| Zan et al. 2016 | RCT | |||||
| Zhang et al. 2018 | RCT |
NM not mentioned, RCT randomized controlled trials, qRCT quasi-randomized controlled trials
AMSTAR Criteria for Included Systematic Reviews
| Items | Parker et al. 2001 | Parker et al. 2004 | Parker et al. 2007 | Zhang et al. 2011 | Zhou et al. 2013 | Chen et al. 2014 | Kelly et al. 2014 | Li | Quinn et al. 2015 | Si | Zan | Zhang et al. 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Was a prior design provided? | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Was there duplicate selection and data extraction? | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Was a comprehensive literature search preformed? | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Was the status of publication used as an inclusion criterion? | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Was a list of included/excluded studies provided? | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| Were the profiles of the included studies provided? | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Was the methodological quality of the included studies evaluated and documented? | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Was the scientific quality of the included studies used appropriately in formulating conclusions? | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Were the methods used to combine the findings of studies appropriate? | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Was the publication bias evaluated? | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
| Were the conflicts of interest stated? | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total score | 9 | 8 | 9 | 7 | 7 | 8 | 6 | 10 | 8 | 7 | 8 | 7 |
Fig. 2Results of each included systematic review. Red means favoring No-Drainage; green means no difference; yellow means not reporting; and blue means favoring Drainage. Arabic numerals mean the number of included randomized clinical trials
Fig. 3Flow diagram of Jadad decision algorithm
Risk of bias assessment of systematic reviews using ROBIS tool
= low risk; = high risk; = unclear risk
Fig. 4Risk of bias of the included systematic reviews with ROBIS tool